Spakinect

Spakinect Discover the simplicity of our virtual good faith evaluations for medical spas. SpaKinect is a physician-owned Medical Corporation.

Our practitioners are compassionate and knowledgeable with expertise in the field of TeleHealth Medicine. We aim to provide excellence in quality, service, and support. SpaKinect offers the most robust TeleHealth solution on the market with proven success in the wellness center industry. Whether you’re starting a new telehealth program, increasing the scope of your current program, or simply want

an effective, low-cost telemonitoring alternative, our Integrated Practitioner Services provide targeted, compassionate care that decreases wellness center costs and improves your patient’s visit. SpaKinect provides expert Telehealth practitioners that operate as a natural extension of your coordinated approval program. We serve as an integrated care team and combine the strengths of your local wellness center team with SpaKinect's centralized Telemedical expertise. The result is a highly effective, efficient, and scalable Telehealth program. SpaKinect can serve as your back-office, integrate your wellness approval protocols in our video conferencing and sophisticated electronic medical record software, and even generate approval letters in real time. By leveraging the latest breakthroughs in information technology, SpaKinect provides Telehealth and "cloud computing" systems with unparalleled advantages for wellness center medical professionals and clinicians. Our systems are designed to produce a digital standardized medical approval record that significantly reduces the cost of running medical wellness centers. Your clinic deserves knowledgeable and compassionate practitioners. From Start to Finish, your experience with SpaKinect will be simple, affordable and stress-free! SpaKinect's Telehealth practitioner experts can help you achieve your program outcome and ROI goals!

Want to continue the conversation on compliance? The real-time discussion is happening in our new Facebook community for...
06/05/2026

Want to continue the conversation on compliance? The real-time discussion is happening in our new Facebook community for US Med Spa operators.

A space for the "is this actually compliant?" questions, the weird patient scenarios, the state board updates nobody's explaining clearly, and the operators who get it.

What we discuss:
→ Patient-Specific Orders & GFEs
→ GLP-1 prescribing, sourcing & documentation
→ State board investigations & audit prep
→ Medical director oversight & supervision
→ State-by-state regulatory shifts

Who belongs:
Med Spa owners, medical directors, NPs, RNs, PAs, and licensed injectors operating in the US.

👉 Search "Med Spa Operators: US Compliance & Regulations" on Facebook, or tap the link to join: https://www.facebook.com/groups/1522494739216249/

🚨 The DOJ just convicted a California physician in a $45M Medicare Botox fraud scheme, and the documentation is what bro...
06/04/2026

🚨 The DOJ just convicted a California physician in a $45M Medicare Botox fraud scheme, and the documentation is what brought the case down.

On May 19, 2026, the U.S. Department of Justice announced the federal conviction of a Glendale, California physician in a Medicare Botox billing case. A federal jury returned guilty verdicts on nine counts of wire fraud and three counts of obstruction of a healthcare criminal investigation. Sentencing is scheduled for September 10, 2026.

Five details from the DOJ trial:
→ Cosmetic Botox billed to Medicare as chronic migraine treatment, despite Medicare's statutory exclusion of cosmetic use
→ Bills submitted on days the physician's travel records placed them in Mexico, Hawaii, Nevada, Pennsylvania, and New York
→ More than $19M in claims tied to thousands of injections allegedly performed on days the clinic was closed
→ At least one claim involving a Medicare beneficiary who was incarcerated in federal prison at the alleged service date
→ Patient charts and consent forms allegedly fabricated or altered, with more altered records provided after a federal grand jury subpoena

After the conviction, the jury also found that vehicles, bank funds, brokerage accounts, and California properties were subject to forfeiture as proceeds of fraud.

Most Med Spas don't bill Medicare. But every Med Spa that offers Botox is operating in the same documentation territory federal investigators just litigated. When records don't match clinic operations, provider availability, or patient records, those gaps become evidence.

What to do now:
✔ Separate cosmetic Botox services from any medical-billing pathway
✔ Reconcile appointment schedules and provider availability with billing records
✔ Document consent forms, treatment indications, and dosing for every Botox service
✔ Verify that medical-necessity Botox claims align with covered diagnoses
✔ Maintain records that hold up under federal-level scrutiny — not just board review

💡 Follow us for more industry insights designed specifically for Med Spa owners.

To read the full article, visit: https://www.spakinect.com/news/california-medicare-botox-billing-fraud-conviction

🚨 The Medical Board just updated 4 major Med Spa rules in Georgia, including a new physician supervision cap.Last week, ...
06/03/2026

🚨 The Medical Board just updated 4 major Med Spa rules in Georgia, including a new physician supervision cap.

Last week, the Georgia Composite Medical Board's Chapter 360 rule updates took effect on May 25, 2026 — affecting physician licensure, APRN nurse protocol agreements, PA supervision, and cosmetic laser practitioner scope.

What changed for the providers in your Med Spa:
→ Physician Licensure: New application requirements include fingerprint-based background checks through the Georgia Crime Information Center and FBI, a Federation Credentials Verification Service (FCVS) report, a National Practitioner Data Bank (NPDB) Self-Query, and residency verification for certain non-citizen applicants. Compliance required by July 1, 2026.
→ APRN & PA Supervision Cap: One physician may now supervise no more than 8 Advanced Practice Registered Nurses (APRNs) and Physician Assistants (PAs) combined.
→ APRN & PA Delegation: Pharmacology training and applicable continuing education are required before delegating authority. Schedule II prescribing remains restricted outside statutory emergency exceptions.
→ Cosmetic Laser Scope: Now includes ultrasound, cryolipolysis, microwave, and radiofrequency procedures used for cosmetic purposes. Assistant laser practitioners may perform these services only under supervision of a licensed physician or senior laser practitioner.

Georgia isn't operating alone. Oklahoma's Board of Nursing guidance in March 2026 addressed provider orders, evaluations, and supervision in Med Spa settings. Virginia's dental board updated cosmetic Botox training rules in May. Together, they signal that states are tightening provider-scope and supervision frameworks for aesthetic services.

What Georgia Med Spas need to do now:
✔ Audit physician-to-provider supervision ratios — the cap is 8 APRNs and PAs combined
✔ Review APRN nurse protocol agreements for delegated authority and prescribing limits
✔ Verify PA job descriptions align with current rules
✔ Assess whether energy-based services now fall under cosmetic laser rules
✔ Confirm assistant laser practitioners are properly supervised

💡 Follow us for more industry insights designed specifically for Med Spa owners.

To read the full article, visit: https://www.spakinect.com/news/georgia-medical-board-chapter-360-rule-updates

🚨 Regulators just updated critical cosmetic Botox protocols in Alabama — and some Med Spas may no longer be compliant.In...
06/02/2026

🚨 Regulators just updated critical cosmetic Botox protocols in Alabama — and some Med Spas may no longer be compliant.

In April 2026, the Alabama Board of Nursing and the Alabama Board of Medical Examiners issued updated protocols for cosmetic Botox injections performed by advanced practice providers (APPs) — including Certified Registered Nurse Practitioners (CRNPs) and Physician Assistants (PAs) — under board-approved arrangements.

5 updates Med Spa operators should know:
→ Dosing: Up to 100 units within a 3-month period (increased from 64 units per session)
→ Treatment areas: All FDA-approved anatomical areas (previously was specific facial muscles only)
→ Practice setting: Administration must occur in a medical setting — private residences and event venues remain prohibited
→ Training: At least 4 hours must be in-person — online-only courses no longer qualify
→ Sourcing: APPs may now purchase Botox with physician approval from an FDA-approved manufacturer

Continuing requirements include on-site physician availability, written board approval before training, observed and supervised procedures, annual competency maintenance, quarterly QA review, and adverse event documentation.

Alabama isn't operating alone. New Jersey's APN law excluded elective aesthetic services from independent-practice expansion. Oklahoma's nursing guidance addresses cosmetic procedures through scope analysis. Together, they signal a shift: aesthetic services are being treated as medical practice, with the standards that come with it.

What to do now:
→ Confirm every APP injecting Botox operates under an approved CRNP or PA pathway
→ Audit training records, including the 4-hour in-person requirement
→ Verify physician on-site availability arrangements match protocol expectations
→ Track dosing limits, FDA-approved anatomical areas, and product sourcing in patient records
→ Document board approval, supervised procedures, QA reviews, and adverse-event follow-up

💡 Follow us for more industry insights designed specifically for Med Spa owners.

To read the full article, visit: https://www.spakinect.com/news/alabama-app-botox-protocol-training-physician-oversight

🚨 Two Iowa state boards just came after the same former Med Spa Advanced Registered Nurse Practitioner (ARNP) — and her ...
06/01/2026

🚨 Two Iowa state boards just came after the same former Med Spa Advanced Registered Nurse Practitioner (ARNP) — and her license is now suspended for at least 12 months.

Last month, the Iowa Board of Nursing accepted a settlement suspending the license of a former Ames hydration spa ARNP for at least 12 months. The Iowa Board of Pharmacy separately filed additional controlled-substance charges shortly after. A related civil trial is scheduled for December 15, 2026.

What the boards alleged:
→ Controlled substances prescribed without corresponding clinical documentation
→ Failure to review the opioid Prescription Monitoring Program as required
→ "Office stock" medications used instead of patient-specific prescriptions
→ Federal controlled-substance registration that didn't match the business or location where the drugs were being used

The structural lesson behind the case: the provider in question served as owner, prescriber, and injector at the same Med Spa. When one person wears every role, every role's compliance is exposed at the same time.

What Med Spa Owners should do now:
✔ Separate clinical, ownership, and medical-director roles in your operating records
✔ Use Patient-Specific Orders for every controlled-substance prescription instead of office stock
✔ Verify PMP review is completed and recorded for opioid prescribing
✔ Confirm CSA registration matches the exact business location where substances are used

Spakinect helps Med Spas deliver compliant patient-specific evaluations with a 100% medical board audit pass rate.

💡 Follow us for more industry insights designed specifically for Med Spa owners.

To read the full article, visit: https://www.spakinect.com/news/iowa-nursing-board-health-spa-arnp-license-suspension

🚨 A new California bill would impose $1,000-per-dose fines on unverified compounded GLP-1s, and bundles sourcing, testin...
05/28/2026

🚨 A new California bill would impose $1,000-per-dose fines on unverified compounded GLP-1s, and bundles sourcing, testing, recordkeeping, and advertising rules into a single statute.

On May 18, 2026, the California State Assembly advanced AB 1990, the bill would create new requirements for certain compounded weight-loss drugs, including GLP-1 receptor agonists.

What AB 1990 would establish:
→ Sourcing standards requiring pharmaceutical-grade ingredients from FDA-registered, FDA-inspected manufacturers, with certificates of analysis on file
→ Quality-control testing before compounded GLP-1s are dispensed, with records retained for Board of Pharmacy review
→ Advertising disclosure rules, including FDA-approved active-ingredient risk information
→ Penalties of $1,000 per dose of illegally compounded drug, plus license revocation when applicable
The bill notably excludes licensed physicians and surgeons from its direct scope, targeting pharmacy-level compounders and the ingredient supply chain. Physicians remain subject to other applicable law.

AB 1990 sits inside a broader GLP-1 enforcement pattern. The FDA issued warning letters to 30 telehealth firms over compounded GLP-1 marketing in March 2026. Connecticut's Attorney General has settled cases tied to compounded GLP-1 advertising. California is now translating those concerns into statute.

California often sets the tone — other states tend to follow.

What Med Spa Owners should do now:
✔ Audit GLP-1 service pages and ads for claims that imply compounded equals FDA-approved
✔ Verify supplier files include sourcing, certificates of analysis, and testing documentation
✔ Maintain internal records of how compounded GLP-1 products are described and sourced
✔ Document the full prescribing and dispensing workflow

💡 Follow Spakinect for more industry insights designed specifically for Med Spa owners.

To read the full article, visit: https://www.spakinect.com/news/california-ab1990-compounded-glp1-sourcing-advertising

Wondering whether you need a new "Patient-Specific Order process" on top of your Good Faith Exams?Short answer: probably...
05/27/2026

Wondering whether you need a new "Patient-Specific Order process" on top of your Good Faith Exams?

Short answer: probably not. A compliant good faith exam already produces the documentation and clinical authorization that a patient-specific order requires — same standard, different name. The real issue is whether your current process can prove it.

Patient-specific orders are reshaping how Med Spa compliance is being discussed and marketed. Here's what the term actually means, how it compares to a good faith exam, and what every operator is asking right now.

💡 Read the full breakdown on our blog, reviewed for legal accuracy by attorneys at Lengea Law here: https://www.spakinect.com/blog/good-faith-exam-vs-patient-specific-order

The FDA's biggest cosmetics oversight law in decades is in active implementation, and Med Spas with retail shelves shoul...
05/26/2026

The FDA's biggest cosmetics oversight law in decades is in active implementation, and Med Spas with retail shelves should know where they stand.

The FDA released updated tools to help cosmetic facilities prepare for biennial registration renewal under the Modernization of Cosmetics Regulation Act of 2022 (MoCRA). The framework covers facility registration, product listing, adverse event reporting, safety substantiation, records access, and mandatory recall authority.

For Med Spas, the key question is whether this applies to them.

The answer comes down to what's on your retail shelf. MoCRA reaches private-label skincare, branded retail products, and any practice involved in manufacturing or processing cosmetics. It does not reach injectables, lasers, peels, or IV therapy — those fall under separate drug and device rules.

But the broader signal matters. Private-label and branded skincare are one of the fastest-growing revenue lines in aesthetics, which means more practices land inside MoCRA's scope every year. This sits alongside FDA activity we've tracked on telehealth GLP-1 marketing and the RAPID device pathway — federal aesthetics oversight is broadening.

What to do now:
→ Inventory every cosmetic product sold through your practice
→ Identify the responsible person for each product
→ Verify private-label documentation covers listing, ingredients, and labeling
→ Maintain supplier records and adverse event routing

💡 Follow Spakinect for more industry insights designed specifically for Med Spa owners.

To read the full article, visit: https://www.spakinect.com/news/fda-mocra-registration-product-listing-cosmetics

🚨 BREAKING: Alabama just became the first state in the country to formally prohibit the prescribing, administering, and ...
05/22/2026

🚨 BREAKING: Alabama just became the first state in the country to formally prohibit the prescribing, administering, and dispensing of research-grade peptides.

On May 21, 2026, the Alabama Board of Medical Examiners and Alabama Medical Licensure Commission issued a joint notice making three things explicit:
→ Physicians must source all prescription products from Board of Pharmacy–permitted entities, and research-grade peptide vendors fall outside that system
→ Prescribing cannot be passed to CRNPs, CNMs, or PAs as a workaround
→ "Research-grade" patient waivers do not protect physicians from professional or legal liability

No other state has gone this far. Alabama is setting the precedent.

For Med Spas, the stakes are real:
→ Peptide therapy has become a core Med Spa revenue line
→ Delegation no longer creates a safe pathway
→ Liability follows the prescriber, regardless of what patients sign
→ Peptide compliance is a fast-moving regulatory area

Operators who get ahead of this now won't be scrambling when the next state moves.

What to do now:
✅ Audit every peptide currently on your service menu
✅ Verify each is FDA-approved and sourced from a permitted pharmacy
✅ Review any prescribing pathways delegated to NPs, PAs, or CNMs
✅ Retire "research-grade" consent forms as a liability shield

💡 Follow Spakinect for more industry insights designed specifically for Med Spa owners.

New Jersey just expanded independent practice authority for certain APNs, but specifically excluded APNs providing elect...
05/12/2026

New Jersey just expanded independent practice authority for certain APNs, but specifically excluded APNs providing elective aesthetic or cosmetic services.

On March 30, 2026, Governor Mikie Sherrill signed S2996/A4052, a law that permanently allows qualifying APNs in primary or behavioral health care to practice without a joint protocol with a collaborating physician. Med Spa APNs were watching this bill closely. The exclusion is deliberate — physician-collaboration requirements remain in place for elective aesthetic care.

Two APN tracks now exist in New Jersey:
→ Primary care APNs: Independent practice allowed (with 5,000+ hours and eligible specialty)
→ Aesthetic APNs: Cannot practice independently — joint protocol still required
The broader trend is consolidating — more states are treating Med Spa supervision as its own regulatory category

How NJ Med Spas stay ahead:
✔ Review APN collaboration agreements for elective aesthetic and cosmetic services
✔ Verify prescribing workflows for injectables, IV therapy, and wellness services
✔ Distinguish primary care from elective aesthetic models when structuring APN practice
✔ Audit medical director oversight and supervision workflows
✔ Document chart review and annual protocol activity to support compliance

💡 Follow Spakinect for more industry insights designed specifically for Med Spa owners.

To read the full article, visit: https://www.spakinect.com/news/new-jersey-s2996-excludes-elective-aesthetic-cosmetic-services-apn-exemption

Address

5405 Morehouse Drive Suite 170
San Diego, CA
92121

Opening Hours

Monday 8am - 7pm
Tuesday 8am - 6pm
Wednesday 8am - 6pm
Thursday 8am - 6pm
Friday 8am - 6pm
Saturday 8am - 6pm

Telephone

+18772668455

Alerts

Be the first to know and let us send you an email when Spakinect posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Featured

Share

Category